Literature DB >> 24708299

Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia.

Jared W Young1, Anil Ratty2, Gavin S Dawe3, Mark A Geyer1.   

Abstract

Schizophrenia is a prevalent neurodevelopmental psychiatric disorder with poor prognosis and limited understanding of its etiology. This limited etiological understanding renders developing animal models of schizophrenia difficult. Although attempts are made to recreate putative etiologies in models, these models may only enable the generation of treatments targeted at the mechanisms manipulated. Although the chakragati mouse was not created as a result of a specific gene target, reports to date suggest these mice exhibit behavioral abnormalities that are consistent with some observed in patients with schizophrenia. As an initial screen on the relevance of these mice to schizophrenia, we tested the exploration and sensorimotor gating of male and female chakragati mice in the cross-species tests behavioral pattern monitor (BPM) and prepulse inhibition (PPI), respectively. The chakragati mice exhibited hyperactive yet more meandering/circling movements of exploration compared with wildtype (WT) littermates. Moreover, chakragati mice exhibited impaired PPI compared with WT mice, primarily at high prepulse intensity levels. Thus, chakragati mice share some of the abnormal exploratory and PPI behaviors that are observed in patients with schizophrenia. These behaviors can be used to screen for novel antipsychotics which may be based on novel mechanisms of action. The multivariate abnormal exploration of these mice may also yield further information for treatment effects. Further characterization of these mice in tasks with putative links to negative or cognitive symptoms may further advance the utility of these mice as a screen for novel treatments for schizophrenia.

Entities:  

Mesh:

Year:  2014        PMID: 24708299      PMCID: PMC4107138          DOI: 10.1037/a0036425

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  49 in total

1.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Do recent-onset schizophrenia patients experience a "social network crisis"?

Authors:  William P Horan; Kenneth L Subotnik; Karen S Snyder; Keith H Nuechterlein
Journal:  Psychiatry       Date:  2006       Impact factor: 2.458

3.  Ventricular size mapping in a transgenic model of schizophrenia.

Authors:  German Torres; Beth A Meeder; Brian H Hallas; Joseph A Spernyak; Richard Mazurchuk; Craig Jones; Kenneth W Gross; Judith M Horowitz
Journal:  Brain Res Dev Brain Res       Date:  2005-01-01

Review 4.  Schizophrenia.

Authors:  M Cannon; P Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

5.  Genetic mapping of two DNA markers, D16Ros1 and D16Ros2, flanking the mutation site in the chakragati mouse, a transgenic insertional mutant.

Authors:  A K Ratty; Y Matsuda; R W Elliott; V M Chapman; K W Gross
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

6.  Symptom correlates of prepulse inhibition deficits in male schizophrenic patients.

Authors:  D L Braff; N R Swerdlow; M A Geyer
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

Review 7.  The neuropathology of schizophrenia. A critical review of the data and their interpretation.

Authors:  P J Harrison
Journal:  Brain       Date:  1999-04       Impact factor: 13.501

8.  Preliminary evidence for reduced social interactions in Chakragati mutants modeling certain symptoms of schizophrenia.

Authors:  German Torres; Beth A Meeder; Brian H Hallas; Kenneth W Gross; Judith M Horowitz
Journal:  Brain Res       Date:  2005-06-07       Impact factor: 3.252

9.  Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.

Authors:  Victoria B Risbrough; Virginia L Masten; Sorana Caldwell; Martin P Paulus; Malcolm J Low; Mark A Geyer
Journal:  Neuropsychopharmacology       Date:  2006-07-19       Impact factor: 7.853

10.  Three independent factors characterize spontaneous rat motor activity.

Authors:  M P Paulus; M A Geyer
Journal:  Behav Brain Res       Date:  1993-02-26       Impact factor: 3.332

View more
  2 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

2.  Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine.

Authors:  T Jordan Walter; Jared W Young; Morgane Milienne-Petiot; D S Deben; Robert K Heaton; Scott Letendre; David J Grelotti; William Perry; Igor Grant; Arpi Minassian
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-09-04       Impact factor: 5.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.